계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Leap Therapeutics
company
About
Leap Therapeutics is a clinical-stage biopharmaceutical company.
- 11 - 50
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $27M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$27M
Leap Therapeutics has raised a total of
$27M
in funding over 2 rounds. Their latest funding was raised on
Jan 3, 2020 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 3, 2020 | Post-IPO Equity | $27M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Leap Therapeutics is funded by 1 investors.
BeiGene
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BeiGene
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
